Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Quiz page February 2012: acute kidney injury in an adolescent with a family history of autoimmune disorders.
Allain-Launay E, Blin N, Moreau A, Roussey-Kesler G.
Am J Kidney Dis. 2012 Feb;59(2):A33-5. No abstract available.
Related citations
APRIL in systemic lupus erythematosus: Essential or dispensable? Comment on the article by Jacob et al.
Pan HF, Wang DG, Ye DQ.
Arthritis Rheum. 2012 Jun;64(6):2052-3. doi: 10.1002/art.34388. Epub 2012 Jan 13. No abstract available.
Can loss of muscle spindle afferents explain the ataxic gait in Riley-Day syndrome?
Macefield VG, Norcliffe-Kaufmann L, Gutiérrez J, Axelrod FB, Kaufmann H.
Brain. 2011 Nov;134(Pt 11):3198-208.
Islet autoantibodies and residual beta cell function in type 1 diabetes children followed for 3-6 years.
Sorensen JS, Vaziri-Sani F, Maziarz M, Kristensen K, Ellerman A, Breslow N, Lernmark A, Pociot F, Brorsson C, Birkebaek NH; on behalf of the Danish Study Group for Childhood Diabetes.
Diabetes Res Clin Pract. 2012 May;96(2):204-210. Epub 2012 Jan 16.
Evidence of a combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimoto's thyroiditis.
Ehlers M, Thiel A, Bernecker C, Porwol D, Papewalis C, Willenberg HS, Schinner S, Hautzel H, Scherbaum WA, Schott M.
J Clin Endocrinol Metab. 2012 Apr;97(4):1347-54. Epub 2012 Jan 18.
Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in mice.
Yolcu ES, Zhao H, Bandura-Morgan L, Lacelle C, Woodward KB, Askenasy N, Shirwan H.
J Immunol. 2011 Dec 1;187(11):5901-9. Epub 2011 Nov 7.
Pathogenic and protective functions of TNF in neuroinflammation are defined by its expression in T lymphocytes and myeloid cells.
Kruglov AA, Lampropoulou V, Fillatreau S, Nedospasov SA.
J Immunol. 2011 Dec 1;187(11):5660-70. Epub 2011 Nov 4.
Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation.
Michels AW, Ostrov DA, Zhang L, Nakayama M, Fuse M, McDaniel K, Roep BO, Gottlieb PA, Atkinson MA, Eisenbarth GS.
J Immunol. 2011 Dec 1;187(11):5921-30. Epub 2011 Oct 31.
Altered differentiation, diminished pathogenicity, and regulatory activity of myelin-specific T cells expressing an enhanced affinity TCR.
Alli R, Nguyen P, Geiger TL.
J Immunol. 2011 Dec 1;187(11):5521-31. Epub 2011 Oct 24.
B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
Sun JB, Czerkinsky C, Holmgren J.
J Immunol. 2012 Feb 15;188(4):1686-97. Epub 2012 Jan 16.
Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G.
J Nephrol. 2012 Jan 16:0. doi: 10.5301/jn.5000069. [Epub ahead of print]
Aberrant expression of the apoptosis-related proteins BAK and MCL1 in T cells in multiple sclerosis.
Mandel I, Paperna T, Miller A.
J Neuroimmunol. 2012 Mar;244(1-2):51-6. Epub 2012 Jan 16.
Human T cell expansion and experimental autoimmune encephalomyelitis inhibited by Lenaldekar, a small molecule discovered in a zebrafish screen.
Cusick MF, Libbey JE, Trede NS, Eckels DD, Fujinami RS.
J Neuroimmunol. 2012 Mar;244(1-2):35-44. Epub 2012 Jan 14.
Upregulation of IL-17, but not of IL-9, in circulating cells of CIS and relapsing MS patients. Impact of corticosteroid therapy on the cytokine network.
Muls N, Jnaoui K, Dang HA, Wauters A, Van Snick J, Sindic CJ, van Pesch V.
J Neuroimmunol. 2012 Feb 29;243(1-2):73-80. Epub 2012 Jan 14.
Analysis of antibodies to surface epitopes of contactin-2 in multiple sclerosis.
Boronat A, Sepúlveda M, Llufriu S, Sabater L, Blanco Y, Gabilondo I, Solà N, Villoslada P, Dalmau J, Graus F, Saiz A.
J Neuroimmunol. 2012 Mar;244(1-2):103-6. Epub 2012 Jan 14.
Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis.
Arabshahi B, Silverman RA, Jones OY, Rider LG.
J Pediatr. 2012 Mar;160(3):520-2. Epub 2012 Jan 13.
Mortality profile related to systemic lupus erythematosus: a multiple cause-of-death analysis.
Souza DC, Santo AH, Sato EI.
J Rheumatol. 2012 Mar;39(3):496-503. Epub 2012 Jan 15.
Propylthiouracil-induced antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis versus primary ANCA-associated renal vasculitis: a comparative study.
Chen YX, Zhang W, Chen XN, Yu HJ, Ni LY, Xu J, Pan XX, Ren H, Chen N.
J Rheumatol. 2012 Mar;39(3):558-63. Epub 2012 Jan 15.
Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
Fragoso-Loyo H, Atisha-Fregoso Y, Núñez-Alvarez CA, Llorente L, Sánchez-Guerrero J.
J Rheumatol. 2012 Mar;39(3):504-9. Epub 2012 Jan 15.
Morbidity, mortality, and organ damage in patients with antiphospholipid syndrome.
Grika EP, Ziakas PD, Zintzaras E, Moutsopoulos HM, Vlachoyiannopoulos PG.
J Rheumatol. 2012 Mar;39(3):516-23. Epub 2012 Jan 15.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on